Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$1.7 million.

  • Q32 Bio's Other Working Capital Changes fell 26004.18% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 9343.23%. This contributed to the annual value of -$1.5 million for FY2024, which is 9403.46% up from last year.
  • Latest data reveals that Q32 Bio reported Other Working Capital Changes of -$1.7 million as of Q3 2025, which was down 26004.18% from $343000.0 recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's Other Working Capital Changes registered a high of $20.6 million during Q3 2023, and its lowest value of -$40.3 million during Q4 2023.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$802000.0 (2021), whereas its average is -$3.5 million.
  • In the last 5 years, Q32 Bio's Other Working Capital Changes tumbled by 6586666.67% in 2021 and then skyrocketed by 272274.46% in 2023.
  • Q32 Bio's Other Working Capital Changes (Quarter) stood at -$802000.0 in 2021, then crashed by 960.97% to -$8.5 million in 2022, then plummeted by 374.06% to -$40.3 million in 2023, then soared by 98.58% to -$572000.0 in 2024, then tumbled by 200.87% to -$1.7 million in 2025.
  • Its Other Working Capital Changes was -$1.7 million in Q3 2025, compared to $343000.0 in Q2 2025 and -$763000.0 in Q1 2025.